Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasis

J Cell Biochem. 2019 Feb;120(2):1141-1155. doi: 10.1002/jcb.26719. Epub 2018 Oct 18.

Abstract

Visceral leishmaniasis (VL) is caused by the parasites of Leishmania donovani complex, leads to the death of 20 000 to 40 000 people from 56 affected countries, worldwide. Till date, there is not a single available vaccine candidate to prevent the VL infection, and treatment only relies upon expensive and toxic chemotherapeutic options. Consequently, immunoinformatics approach was applied to design a multiepitope-based subunit vaccine to enhance the humoral as well as cell-mediated immunity. Constructed vaccine candidate was further subjected to evaluation on allergenicity and antigenicity and physiochemical parameters. Later on, disulfide engineering was performed to increase the stability of vaccine construct. Also, molecular docking and molecular dynamics simulation study were performed to check the binding affinity and stability of toll-like receptor-4 to vaccine construct complex. Finally, codon optimization and in silico cloning were performed to ensure the expression of proposed vaccine construct in a microbial expression system.

Keywords: disulfide engineering; humoral immunity; in silico cloning; salivary protein; sand fly; subunit vaccine.